Seaport Res Ptn Cuts Earnings Estimates for Aspen Aerogels

Aspen Aerogels, Inc. (NYSE:ASPNFree Report) – Equities research analysts at Seaport Res Ptn lowered their FY2024 earnings estimates for shares of Aspen Aerogels in a report issued on Monday, November 11th. Seaport Res Ptn analyst T. Curran now anticipates that the construction company will post earnings per share of $0.11 for the year, down from their prior estimate of $0.19. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.11 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels’ Q4 2024 earnings at $0.09 EPS, Q1 2025 earnings at $0.06 EPS, Q2 2025 earnings at $0.16 EPS, Q3 2025 earnings at $0.19 EPS, Q4 2025 earnings at $0.19 EPS, FY2025 earnings at $0.60 EPS and FY2026 earnings at $0.83 EPS.

ASPN has been the topic of several other research reports. StockNews.com upgraded Aspen Aerogels to a “sell” rating in a report on Wednesday. Piper Sandler cut their price target on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Barclays reduced their price target on shares of Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Tuesday. HC Wainwright restated a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. Finally, Roth Mkm reduced their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating on the stock in a report on Friday, November 8th. One investment analyst has rated the stock with a sell rating, nine have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $28.70.

View Our Latest Analysis on ASPN

Aspen Aerogels Stock Down 2.7 %

NYSE:ASPN opened at $15.12 on Thursday. Aspen Aerogels has a 52 week low of $9.89 and a 52 week high of $33.15. The stock’s fifty day moving average is $22.44 and its two-hundred day moving average is $24.67. The stock has a market capitalization of $1.24 billion, a price-to-earnings ratio of 1,553.55 and a beta of 2.21. The company has a quick ratio of 2.82, a current ratio of 2.93 and a debt-to-equity ratio of 0.27.

Institutional Investors Weigh In On Aspen Aerogels

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Point72 Hong Kong Ltd acquired a new position in Aspen Aerogels during the second quarter worth approximately $84,000. nVerses Capital LLC purchased a new position in shares of Aspen Aerogels during the second quarter worth approximately $95,000. Quent Capital LLC acquired a new position in shares of Aspen Aerogels in the 3rd quarter valued at $118,000. Point72 DIFC Ltd purchased a new stake in Aspen Aerogels in the 2nd quarter valued at $121,000. Finally, Public Employees Retirement Association of Colorado purchased a new stake in Aspen Aerogels in the 2nd quarter valued at $145,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Aspen Aerogels

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the transaction, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at $626,610.60. This represents a 60.96 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the sale, the chief executive officer now directly owns 483,640 shares in the company, valued at approximately $14,523,709.20. The trade was a 11.58 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Read More

Earnings History and Estimates for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.